BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25917877)

  • 1. Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants.
    Thys K; Verhasselt P; Reumers J; Verbist BM; Maes B; Aerssens J
    J Virol Methods; 2015 Sep; 221():29-38. PubMed ID: 25917877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering.
    Verbist BM; Thys K; Reumers J; Wetzels Y; Van der Borght K; Talloen W; Aerssens J; Clement L; Thas O
    Bioinformatics; 2015 Jan; 31(1):94-101. PubMed ID: 25178459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of a newly developed automated massively parallel sequencing assay for hepatitis C virus genotyping and detection of resistance-association variants. Comparison with a line probe assay.
    Manee N; Thongbaiphet N; Pasomsub E; Chantratita W
    J Virol Methods; 2017 Nov; 249():31-37. PubMed ID: 28851606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of illumina deep sequencing technology to differentiate hepatitis C virus variants.
    Ninomiya M; Ueno Y; Funayama R; Nagashima T; Nishida Y; Kondo Y; Inoue J; Kakazu E; Kimura O; Nakayama K; Shimosegawa T
    J Clin Microbiol; 2012 Mar; 50(3):857-66. PubMed ID: 22205816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing to assess HIV tropism.
    Swenson LC; Däumer M; Paredes R
    Curr Opin HIV AIDS; 2012 Sep; 7(5):478-85. PubMed ID: 22832710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of HCV NS3 protease variability and resistance-associated mutations assessed by next generation sequencing in HCV monoinfected and HIV/HCV coinfected patients.
    Bartolini B; Giombini E; Zaccaro P; Selleri M; Rozera G; Abbate I; Comandini UV; Ippolito G; Solmone M; Capobianchi MR
    Virus Res; 2013 Nov; 177(2):205-8. PubMed ID: 23954579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QQ-SNV: single nucleotide variant detection at low frequency by comparing the quality quantiles.
    Van der Borght K; Thys K; Wetzels Y; Clement L; Verbist B; Reumers J; van Vlijmen H; Aerssens J
    BMC Bioinformatics; 2015 Nov; 16():379. PubMed ID: 26554718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ViVaMBC: estimating viral sequence variation in complex populations from illumina deep-sequencing data using model-based clustering.
    Verbist B; Clement L; Reumers J; Thys K; Vapirev A; Talloen W; Wetzels Y; Meys J; Aerssens J; Bijnens L; Thas O
    BMC Bioinformatics; 2015 Feb; 16():59. PubMed ID: 25887734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sequencing of HIV: clinical and research applications.
    Chabria SB; Gupta S; Kozal MJ
    Annu Rev Genomics Hum Genet; 2014; 15():295-325. PubMed ID: 24821496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
    Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
    J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the hepatitis C virus genome using single molecule real-time sequencing.
    Takeda H; Yamashita T; Ueda Y; Sekine A
    World J Gastroenterol; 2019 Aug; 25(32):4661-4672. PubMed ID: 31528092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of next-generation sequencing technologies to diagnostic virology.
    Barzon L; Lavezzo E; Militello V; Toppo S; Palù G
    Int J Mol Sci; 2011; 12(11):7861-84. PubMed ID: 22174638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing.
    Montoya V; Olmstead A; Tang P; Cook D; Janjua N; Grebely J; Jacka B; Poon AF; Krajden M
    Infect Genet Evol; 2016 Sep; 43():329-37. PubMed ID: 27282472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing.
    McClenahan SD; Uhlenhaut C; Krause PR
    Vaccine; 2014 Dec; 32(52):7115-21. PubMed ID: 25454874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women.
    Minosse C; Calcaterra S; Abbate I; Selleri M; Zaniratti MS; Capobianchi MR
    J Infect Dis; 2006 Dec; 194(11):1529-36. PubMed ID: 17083037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory.
    Ram D; Leshkowitz D; Gonzalez D; Forer R; Levy I; Chowers M; Lorber M; Hindiyeh M; Mendelson E; Mor O
    J Virol Methods; 2015 Feb; 212():12-6. PubMed ID: 25445792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of an automated nucleic acid extractor (easyMAG) for use with hepatitis C virus and human immunodeficiency virus type 1 nucleic acid amplification testing.
    Jarvis LM; Mulligan K; Dunsford TH; McGowan K; Petrik J
    J Virol Methods; 2011 Feb; 171(2):364-8. PubMed ID: 21126541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral population analysis and minority-variant detection using short read next-generation sequencing.
    Watson SJ; Welkers MR; Depledge DP; Coulter E; Breuer JM; de Jong MD; Kellam P
    Philos Trans R Soc Lond B Biol Sci; 2013 Mar; 368(1614):20120205. PubMed ID: 23382427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.